Lifeline Biotechnologies Inc (LLBO)

[Domains]

If sales are a success: over $0.10

Read my previous messages, taking into account that now it's confirmed we own 45% of Cyrcadia, Inc (US) and not the 40% stated there.

LLBO should be now at $0.004 and rise steadily in the coming months
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132386032

Sales and income projection (100K-10M units sold)
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=131892724

The pros:

- LLBO stock price has increased 300% over the last three months.
- Cyrcadia has 3 patents in the US and other pending worldwide.
- The Detected movie will should be available in Internet after the summer.
- CISCO promotes Cyrcadia (iTbra) as an example of IoT/AI success but has not done a media campaign yet.
- FDA Class I approval can arrive at any time before the end of 2017.
- iTbra accuracy is higher than mamograms (87% vs. 83%)
- Cyrcadia Asia will start selling the iTbra + app by the beginning of 2018
- Cyrcadia Asia expects to screen over 3 millions women in one year.
- Cyrcadia, Inc (US) should start selling in the US by the beginning of 2018.
- Cyrcadia has hired the top healthcare advertising agency: Area 23
- The iTbra has a Class II clearance (tested on 500 patients) will be used to start selling the services through hospitals by the beginning of 2018.
- The iTbra will be sold later on as a product over-the-counter when receiving FDA Class I approval.
- The iTbra cost/year OTC should be around $200
- The iTbra cost/use though the hospital should be the same as a mamogram.
- The iTbra will help reduce 500,000 unnecessary biopsies in the US
- Cyrcadia claims to have 500,000 anticipated orders in 2017

Do your own due diligence before investing. But be sure that this is a real company with the support of CISCO. Some people are trying desperately to lower the price, but the fact is that anything below $0.004 is unrealistic according to the current official information.